Veltassa and Fosrenol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Veltassa (patiromer sorbitex calcium) and Fosrenol (lanthanum carbonate). Common drug interactions include hospitalisation among females and constipation among males.

The phase IV clinical study analyzes what interactions people have when they take Veltassa and Fosrenol. It is created by eHealthMe based on reports of 96 people who take the same drugs from the FDA, and is updated regularly.

What is Veltassa?

Veltassa has active ingredients of patiromer sorbitex calcium. eHealthMe is studying from 15,649 Veltassa users. Check the latest studies of Veltassa.

What is Fosrenol?

Fosrenol has active ingredients of lanthanum carbonate. eHealthMe is studying from 5,922 Fosrenol users. Check the latest studies of Fosrenol.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 04, 2026

96 people who take Veltassa and Fosrenol together, and have interactions are studied.

Veltassa and Fosrenol drug interactions.

What are the common drug interactions of Veltassa and Fosrenol, by gender? *:

female:

  1. Hospitalisation
  2. Death
  3. Constipation
  4. Pneumonia
  5. Diarrhoea
  6. Pruritus (severe itching of the skin)
  7. Adverse event
  8. Blood potassium decreased
  9. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  10. Drug hypersensitivity

male:

  1. Constipation
  2. Death
  3. Dehydration (dryness resulting from the removal of water)
  4. Diarrhoea
  5. Flatulence (flatus expelled through the anus)
  6. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  7. Anxiety
  8. Blood pressure increased
  9. Colitis ischaemic (due to infection of intestine impaired blood supply to colon)
  10. Decreased activity

What are the common drug interactions of Veltassa and Fosrenol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Hidradenitis (chronic disease of a type of sweat gland)
  2. Wound
  3. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  4. Anxiety
  5. Decreased activity
  6. Emotional distress
  7. Fatigue (feeling of tiredness)
  8. Pain
  9. Pruritus (severe itching of the skin)
  10. Quality of life decreased

50-59:

  1. Constipation
  2. Death
  3. Hospitalisation
  4. Diarrhoea
  5. Abdominal discomfort
  6. Drug ineffective
  7. Fall
  8. Hypotension (abnormally low blood pressure)
  9. Ligament sprain (ligament stretched)
  10. Malaise (a feeling of general discomfort or uneasiness)

60+:

  1. Diarrhoea
  2. Postoperative wound infection
  3. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  4. Hospitalisation
  5. Rehabilitation therapy
  6. Adverse event
  7. Ageusia (loss of taste functions of the tongue)
  8. Asthenia (weakness)
  9. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  10. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)

What are the existing conditions these people have? *

  1. Hyperkalemia (damage to or disease of the kidney): 92 people, 95.83%

* Approximation only. Some reports may have incomplete information.

Do you take Veltassa and Fosrenol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Veltassa and Fosrenol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Veltassa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Fosrenol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Veltassa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Fosrenol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on patiromer sorbitex calcium and lanthanum carbonate (the active ingredients of Veltassa and Fosrenol, respectively), and Veltassa and Fosrenol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: